Sonnet BioTherapeutics Holdings, Inc. (SONN)
NASDAQ: SONN · IEX Real-Time Price · USD
0.850
-0.014 (-1.59%)
At close: Jul 19, 2024, 4:00 PM
0.930
+0.080 (9.41%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

SONN Income Statement

Millions USD. Fiscal year is Oct - Sep.
Year Ending
TTM Sep 30, 2023Sep 30, 2022Sep 30, 2021Sep 30, 2020Sep 30, 2019 2018 - 2004
Revenue
0.090.150.350.4800
Upgrade
Revenue Growth (YoY)
-53.29%-57.76%-27.64%---
Upgrade
Gross Profit
0.090.150.350.4800
Upgrade
Selling, General & Admin
5.697.138.588.947.532.51
Upgrade
Research & Development
7.0611.8121.4416.639.882.2
Upgrade
Other Operating Expenses
00006.830
Upgrade
Operating Expenses
12.7618.9430.0225.5724.244.71
Upgrade
Operating Income
-12.66-18.79-29.67-25.09-24.24-4.71
Upgrade
Interest Expense / Income
000000.16
Upgrade
Other Expense / Income
-4.240.040.05-0.10.03-
Upgrade
Pretax Income
-8.43-18.83-29.72-24.98-24.27-4.87
Upgrade
Net Income
-8.43-18.83-29.72-24.98-24.27-4.87
Upgrade
Preferred Dividends
000041.340
Upgrade
Net Income Common
-8.43-18.83-29.72-24.98-65.6-4.87
Upgrade
Shares Outstanding (Basic)
510000
Upgrade
Shares Outstanding (Diluted)
510000
Upgrade
Shares Change
550.94%425.77%147.76%160.57%76.15%3846.36%
Upgrade
EPS (Basic)
-2.31-18.14-150.52-313.50-2143.68-280.28
Upgrade
EPS (Diluted)
-2.32-18.14-150.52-313.50-2143.68-280.28
Upgrade
Free Cash Flow
-13.1-21.34-27.77-22.56-15.69-2.23
Upgrade
Free Cash Flow Per Share
-2.84-20.56-140.65-283.01-513.01-128.18
Upgrade
Gross Margin
100.00%100.00%100.00%100.00%--
Upgrade
Operating Margin
-13655.51%-12714.47%-8478.34%-5187.36%--
Upgrade
Profit Margin
-9087.11%-12741.58%-8493.34%-5165.97%--
Upgrade
Free Cash Flow Margin
-14125.89%-14439.19%-7936.59%-4663.91%--
Upgrade
EBITDA
-8.35-18.76-29.63-24.89-24.21-4.71
Upgrade
EBITDA Margin
-9002.01%-12690.33%-8466.69%-5146.29%--
Upgrade
Depreciation & Amortization
0.080.080.090.10.060
Upgrade
EBIT
-8.43-18.83-29.72-24.98-24.27-4.71
Upgrade
EBIT Margin
-9087.11%-12741.58%-8493.34%-5165.97%--
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).